Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

The niosomal gel effectively delivers testosterone through the skin with fewer side effects.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Different solvents change minoxidil crystal shapes and improve flowability.

Different solvents affect minoxidil crystal shapes, improving flowability and revealing a unique butterfly-shaped crystal.

The technique effectively shows how human skin and hair cells form into ball-like structures.

Human stem cells can turn into functional eye cells that might help treat retinal diseases.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Clofazimine may be effective for treating ashy dermatosis.

Steers with winter hair coats and reduced sweating struggled with heat, leading to less grazing and poor performance.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

CHIR99021 helps create human skin with hair follicles, offering hope for hair loss treatments.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

3D spheroid culture makes stem cells better at reducing inflammation.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

The compound 4c effectively inhibits the enzyme linked to hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

3D spheroid cells effectively test hair growth compounds like Minoxidil.

3D spheroid cultures of human hair follicle cells are better for hair growth research than 2D cultures, and they provide new insights into how hair growth treatments like minoxidil and TCQA work.

Culturing Dermal Papilla Cells and Hair Follicle Stem Cells in 3D conditions can significantly improve hair regeneration potential.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Silibinin may help hair growth and treat hair loss.